Antipsychotic Medications Flashcards

1
Q

conditions managed with antipsychotics

A
  • Schizophrenia
  • Bipolar Disorder
  • Severe Depression
  • Substance Abuse (maybe symptom of above)\

Manage severe agitation
Lesser uses: nausea, vomiting, hiccups

Sometimes used to treat dementia but must use caution - Very seldome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

three types of symptoms for schizophrenia

A

positive
negative
cognitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Positive

A
Exaggeration or distortion of
normal function
Hallucinations 
Delusions 
Agitation
Tension 
Paranoia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Negative

A
Loss or diminution of normal
function
Lack of motivation 
Poverty of speech
Blunted affect 
Poor self-care 
Social withdrawal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cognitive

A
Disordered thinking
Reduced ability to focus attention
Prominent learning and memory
difficulties
Subtle changes*
Florid changes: Thinking and
speech may be completely
incomprehensible to others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Primary neurotransmitter at work when we talk about schizophrenia

A

dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Underactivity of D1 receptor

A

negative symtpoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Overactivity of D2 receptors

A

positive symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Three major objectives of treatment for shizophrenia

A
  • Suppression of acute episodes
  • Prevention of acute exacerbations
  • Maintenance of the highest possible level of functioning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Strategic and therapeutic considerations for treatment of schizophernia

A
  • Drug selection
  • Dosing
  • Route
  • Oral (tablets, capsules, and liquids)
  • Intramuscular
  • Inhaled
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

First Gen Examples

A
Chlorpromazine
(Thorazine)
Fluphenazine(Prolixin)
Perphenazine (Trilafon)
Trifluoperazine (Stelazine)
Thioridizine (Mellaril)
Thiothixene (Navane)
Haloperidol (Haldol)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2nd Gen

A
Olanzapine (Zyprexa)
Clozapine (Clozaril)
Risperidone (Risperdal)
Quetiapine (Seroquel)
Ziprasidone (Geodon)
Aripiprazole (Abilify)
Paliperidone (Invega)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Typical action

A

Blocks post-synaptic D2 receptors in basal
ganglia, hypothalamus, limbic system and
medulla; lipid soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atypical action

A

Less D2 blockade than the typicals. Hypothesis:
blocks serotonin receptors in cortex which
decreases inhibition of dopamine; thus more effect
on negative symptoms of schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Typical intended effects

A
Reduces positive symptoms of Schizophrenia
(hallucinations, tics)
Treatment of nausea, vomiting, hiccups
Reduces aggressive behaviors
Not much effect on negative symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Atypical intended effects

A

Reduces positive symptoms of schizophrenia but
less than typicals
Reduces negative effects of schizophrenia
Also used to augment treatment of bipolar disorder, depression, delusional disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Typical side effects

A
Extrapyramidal effects (EPS); tardive
dyskinesia
Anticholinergic effects
Adrenergic effects
Prolonged QT
Sedation
Hyperprolactinemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

A typical side effects

A

Less risk of EPS, tardive dyskinesia
Metabolic syndrome: insulin resistance, weight
gain*, hyperprolactinemia
Seizures, tachycardia,dizziness, sleep problems,
constipation, rhinitis
Prolonged QT
Sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Typical contraidincatiosn precaustions

A

Narrow angle glaucoma, severe liver or CVD,
bone marrow depression.
Caution: epilepsy, BPH, DM, CNS tumors.
mortality psychosis of dementia in elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Atypical contraindications/precautions

A

Drug specific

*wt gain differs by agent

21
Q

METABOLISM AND

ELIMINATION

A

Liver
• Thorough metabolism: N+-oxidation, N-glucuronidation, and phases 1 and 2
biotransformation with final glucuronidation before renal excretion.
• Reduce dose elderly or patients with liver disease
Kidney (partially excreted) Kidney (partially excreted)
• Most drugs: <50% of drug eliminated unchanged by renals
• Reduce dose in renal impairment (see later slide)

22
Q

Antipsychotic initiation

A

(first 7 days)
Goal: reduce agitation, tension, anxiety, hostility, aggression
Titrate up over several days; dose is about 50% of chronic dose
Monitor BP

23
Q

Antipsychotic stabilization

A

(6-12 wks)
Goal: increase socialization, self-care habits over first 4 weeks
Thought disorder improvement another 6 weeks
Should see improvement 4-12 weeks
Can use rating scale to evaluate efficacy [+/- Symptom scale (PANNS), brief
psychiatric rating scale (BPRS)}

24
Q

Antipsychotic Maintenance

A

Continue at least 12 months; may be lifetime

Taper slowly to avoid withdrawal

25
Q

What drugs increase effects of antipsychotics

A
Antihypertensives
CNS depressants
Fluvoxamine
Cipro
Other Antipsychotics
Anticholinergics
Lithium
Drugs that prolong QT
26
Q

Drugs that decrease effects

A

Anticonvulsants

Tobacco

27
Q

Typicals Monitoring

A

• Baseline: Assess for dementia; weight, labs: renal, liver, motor function; consider
EKG
• Ongoing: motor function (Abnormal Involuntary Movement Scale or AIMS),
Dyskinesia Identification System: Condensed User Scale (DISCUS); PROLACTIN, BP,
EKG, tardive dyskinesia, seizures
• AIMS http://www.cqaimh.org/pdf/tool_aims.pdf DISCUS
http://www.dhs.state.mn.us/main/groups/licensing/documents/pub/dhs_id_057837.pdf

28
Q

Atypical Monitoring

A
  • Baseline: waist circumference, BMI, BP, FBS, lipid profile.
  • Repeat labs at 3 months, BMI quarterly
  • Annual: BP, labs, waist circumference. Clozapine: CBC
29
Q

Definition of bipolar disorder (BPD)

A
  • Cyclic disorder
  • Recurrent fluctuations in mood
  • Episodes of mania and depression persist for months without treatment
30
Q

Types of mood episodes seen with BPD

A
  • Pure manic episode (euphoric mania) Pure manic episode (euphoric mania)
  • Hypomanic episode (hypomania)
  • Major depressive episode (depression)
  • Mixed episode
31
Q

Treatment for BPD

A
  • Drugs

* Psychotherapy

32
Q

Types of Drugs used for bi poloar disorder

A

mood stabilizers
antipsychotics
antidepressants

33
Q

bpd mood stabilizers

A

Lithium, divalproex sodium, and carbamazepine
• Relieve symptoms during manic and depressive episodes
• Prevent recurrence of manic and depressive episodes
• Do not worsen symptoms of mania or depression; do not accelerate the rate of cycling Do not worsen symptoms of mania or depression; do not accelerate the rate of cycling

34
Q

bpd antipsychotics

A

given during severe manic episodes

35
Q

bpd antidepressants

A

given during depressive episodes

36
Q

SNRI caution with bpd

A

can throw them into a manic episode

37
Q

bpd drug selection

A

• Short-term therapy for manic episodes: Lithium and valproate
• Short-term therapy for depressive episodes: Lithium or valproate, bupropion,
venlafaxine, or a selective serotonin reuptake inhibitor
• Long term preventive treatment: Antipsychotic agents

38
Q

bpd supporting compliance

A
  • Short-term hospitalization
  • Long-term prophylactic therapy
  • Education for both patient and family
39
Q

antipsychotids four facts when treating bpd

A

Used to acutely control symptoms during manic episodes
Used long term to help stabilize mood
Benefit patients with or without psychotic symptoms
Can be combined with mood stabilizer

40
Q

antipsychotics approved for use in bpd

A

• Olanzapine [Zyprexa], quetiapine [Seroquel], risperidone [Risperdal],
aripiprazole [Abilify], and ziprasidone [Geodon]

41
Q

Lithium therapeutic uses

A
  • BPD
  • Other uses
  • Alcoholism
  • Bulimia
  • Schizophrenia
  • Glucocorticoid-induced psychosis
42
Q

Lithium MOA

A
  • Neurotrophic

* Neuroprotective

43
Q

Lithium excretion

A
  • Short half-life
  • Excreted by the kidneys
  • Sodium levels: Lithium excretion reduced when sodium level is low
  • Plasma levels
  • 0.8 to 1.4 mEq/
44
Q

Lithium plasma range

A

0.8 to 1.4

45
Q

• Excessive lithium levels

A

• Greater than 1.5 mEq/L

46
Q

Monitor lithium levels every

A

2 to 3 days at initiation of therapy and then every 3 to 6 months

47
Q

lithium adverse effects

A
  • Gastrointestinal effects
  • Tremors
  • Polyuria
  • Renal toxicity
  • Goiter and hypothyroidism
  • Teratogenesis
48
Q

Lithium drug interactions

A
  • Diuretics
  • Nonsteroidal antiinflammatory drugs
  • Anticholinergic drugs
49
Q

Lithium preperation, dosage and administration

A
  • Lithium carbonate
  • Lithium citrate
  • Dosage is highly individualized